The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge.
Published: 04 Feb 2025
Citation: Toprak Ş, Albayrak M, Aliefendioğlu D. Can platelet and leukocyte counts guide the early prediction of neonatal sepsis? J Curr Hematol Oncol Res. 2025;3(1):1-5.
Published: 04 Feb 2025
Citation: Solmaz ÖA, Ayyıldız H, Oğraş MS. The importance of acidic microenvironment in urothelial carcinomas of the bladder: relationship with carbonic anhydrase IX expression and prognostic factors. J Curr Hematol Oncol Res. 2025;3(1):6-10.
Published: 04 Feb 2025
Citation: Uzun A, Kuku İ, Kaya E, Erkurt MA. Etiologic evaluation of male patients diagnosed with anemia ın the first consultation of the hematology department. J Curr Hematol Oncol Res. 2025;3(1):11-14.
Published: 04 Feb 2025
Citation: Çiftciler R, Karabağlı P, Şahinoğlu M, Karabağlı H. Pituitary extramedullary plasmacytoma without any systemic involvement: a rare case report. J Curr Hematol Oncol Res. 2025;3(1):15-17.
Published: 04 Feb 2025
Citation: Ünal S. Comprehensive management of concurrent chronic lymphocytic leukemia (CLL) and evans syndrome: combinating rituximab, venetoclax and eltrombopag. J Curr Hematol Oncol Res. 2025;3(1):18-19.
Published: 04 Feb 2025
Citation: Başpınar B, Güven İE. Letter: Evaluation of the frequency of hepatitis B virus reactivation and the importance of hepatitis B prophylaxis in hematology patients receiving immunosuppressive therapy: a single-center study. J Curr Hematol Oncol Res. 2025;3(1):20-21.
Published: 30 Aug 2023
Citation: Barış Iİ, Büyükbayram H. ß-catenin expression in myelodysplastic syndromes and myeloproliferative neoplasms in bone marrow, in relation to CD34 and CD117 status. J Curr Hematol Oncol Res. 2023;1(3):54-58.
Published: 30 Aug 2023
Citation: Fidan K. Chronic lymphocytic leukemia. J Curr Hematol Oncol Res. 2023;1(3):59-67.
Published: 26 Feb 2023
Citation: Kaya A, Berber İ, Kuku İ, et al. Effect of tyrosine kinase inhibitor and conventional chemotherapy on COVID-19 antibody level in hematological patients. J Curr Hematol Oncol Res. 2023; 1(1): 1-4